Jackson, MS - New research suggests that mycophenolate mofetil (MMF) can be used in the management of autoimmune inflammatory myopathy. The finding, published in the March 2005 issue of Rheumatology, ...
Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L demonstrated clinically meaningful efficacy and a significant reduction in steroid use within 6 months in Idiopathic ...
Early-onset IBM challenges age-centric diagnostic criteria, with symptoms appearing in patients younger than 46. Younger IBM patients show a higher rate of mitochondrial DNA mutations, indicating ...
A new study has suggested that treatment to target necroptosis in muscle fibers using a necroptosis inhibitor lessens myositis-induced muscle weakness as well as muscle cell death and inflammation in ...
Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — High risk factors for cancer in patients with idiopathic inflammatory myopathy include ...
Despite modern medical therapies, multiorgan idiopathic inflammatory myopathies (IIM) are associated with reduced quality of life and life expectancy. A systematic review of all published ...
Nearly one-third of PM/DM patients are readmitted within 180 days. Common causes of readmission include PM exacerbations and sepsis. Female patients, obese patients, patients with comorbid conditions, ...
Tu, H. and Huang, Y.Y. (2026) Progress in Quantitative Imaging Assessment of Dermatomyositis-Associated Interstitial Lung ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The mean annual direct and indirect costs ...
The MarketWatch News Department was not involved in the creation of this content. -- Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L demonstrated clinically meaningful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results